High-Dose PEG-Asparaginase Before Allogeneic Hematopoietic Stem Cell Transplantation in Acute Lymphoblastic Leukemia: Dose Effect or Surrogate of Pediatric-Inspired Therapy? [0.03%]
高剂量聚乙二醇化天冬酰胺酶在急性淋巴细胞白血病allo-HSCT前使用：是剂量效应，还是儿科启发疗法的替代标志？
Zehra Narli Özdemir,Muhit Özcan
Zehra Narli Özdemir
Biogenic Selenium Nanoparticles Potentiate Anti-Mesothelin CAR-T Cell Therapy in a Syngeneic TNBC Model [0.03%]
生物硒纳米颗粒能增强抗mesothelin CAR-T细胞治疗在同基因型三阴性乳腺癌模型中的疗效
Mina Hosseini,Zahra Shahosseini,Ahmad Reza Panahi Meymandi et al.
Mina Hosseini et al.
Background: Triple-negative breast cancer (TNBC) remains a highly aggressive subtype lacking effective targeted therapies. Although chimeric antigen receptor (CAR)-T cell therapy has transformed the treatment of hematolog...
Keith M Sullivan
Keith M Sullivan
Nausheen Ahmed,Zahra Mahmoudjafari
Nausheen Ahmed
Stephen J Forman
Stephen J Forman
Donor search and selection strategy to facilitate comparable transplant rates across donor search prognosis groups: A report from the BMT CTN 1702 trial [0.03%]
促进不同供者检索预后组之间移植率相当的供者检索与选择策略：BMT CTN 1702 研究报告
Joseph Pidala,Brent Logan,Stephanie J Lee et al.
Joseph Pidala et al.
Background/objective: In a secondary analysis from the BMT CTN 1702 trial, we report on donor search and selection strategies per baseline recipient search prognosis (SP). ...
Disparities in Allogeneic Hematopoietic Stem Cell Transplantation Among Acute Myeloid Leukemia Patients [0.03%]
急性髓系白血病患者allo-HSCT的差异性分析
Lixin Cindy Kang,Mark A Fiala,Kimberly J Johnson
Lixin Cindy Kang
Background: Acute myeloid leukemia (AML) is the most prevalent form of leukemia. Allogeneic hematopoietic cell transplantation (Allo-HCT) is the most effective treatment for most AML subtypes and remains the only curative...
SEVERE VANISHING BILE DUCT SYNDROME AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PEDIATRIC PATIENTS [0.03%]
儿童造血干细胞移植后严重的胆管消失综合征
Giulia Ferrando,Sara Pestarino,Sara Napolitano et al.
Giulia Ferrando et al.
Towards Better Response Assessment of Cutaneous Chronic Graft-Versus-Host Disease: A Report from the National Institutes of Health Consensus Project Task Force [0.03%]
NIH共识项目任务组关于更好的评估皮肤慢性移植物抗宿主病反应的报告
Alina Markova,Stephanie J Lee,Badri Modi et al.
Alina Markova et al.
The National Institutes of Health (NIH) chronic graft-versus-host disease (cGVHD) Consensus Project established response criteria that enabled clinical trials and facilitated regulatory approval of multiple therapies. Nonetheless, organ-spe...